Introduction: The purpose of this study is to investigate the efficacy of core decompression for treating osteonecrosis of the ankle, including the distal tibia and talus, compared to nonoperative management. A systematic review was performed to specifically evaluate: (1) clinical results (patient-reported pain as well as functional scores, physician clinical reported assessment); (2) radiographic outcomes (i.e., radiographic progression of collapse); and (3) need for further procedures.
Materials And Methods: A search of PubMed, EMBASE, and the Cochrane Library found eight reports that fit the inclusion criteria for core decompression or nonoperative management of osteonecrosis of the ankle. Four studies totaling 194 ankles diagnosed with osteonecrosis that underwent core decompression were analyzed. An additional four papers examined 64 ankles diagnosed with osteonecrosis that underwent nonoperative management. Level of evidence of the studies ranged from II to IV. Outcomes of core decompression and nonoperative management analyzed clinical scores such as the American Foot and Ankle Severity Score (AOFASS) and Mazur ankle grading system. Radiographic progression was studied with Ficat and Arlet as well as Hawkins scores.
Results: Overall, there was an improvement in clinical scores and decreased radiographic progression in ankles treated with core decompression. AOFASS scores rose from 41.5 + 0.7 to 89 + 0.7, while the mean Mazur score increased from 34.5 + 0.7 preoperatively to 91.5 + 0.7 postoperatively. After core decompression, only 21% (40 out of 194 ankles) progressed radiographically to Ficat and Arlet stage III or IV postoperatively. Furthermore, core decompression showed less requirement for further surgical management compared to nonoperative management.
Conclusions: Osteonecrosis of the ankle is not as commonly encountered in practice compared to other joints, such as the hips and knees. The results of this study suggest that core decompression is a successful option for treating osteonecrosis of the ankle.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.52198/22.STI.41.OS1619 | DOI Listing |
J Shoulder Elbow Surg
January 2025
Maimonides Medical Center, Department of Orthopaedic Surgery and Rehabilitation, Brooklyn, NY, USA.
Introduction: The humeral head is the second most common site for osteonecrosis but its epidemiology is poorly described. This study aimed to better understand its treatment in the United States by 1) evaluating total operative procedures with rates normalized to the annual surgical volume; 2) determining trends of non-joint preserving (shoulder arthroplasty) vs. joint preserving procedures; and 3) quantifying rates of operative techniques in different aged cohorts (<50 vs.
View Article and Find Full Text PDFJ Orthop Surg Res
January 2025
Department of Orthopaedics and Traumatology, University of Health Sciences, Adana City Training and Research Hospital, Adana, Turkey.
Background: Avascular necrosis (AVN) of the femoral head is a degenerative condition characterized by ischemic bone death, resulting in pain and impaired mobility. Core decompression, a surgical intervention, is widely performed for stage II AVN to alleviate symptoms and delay disease progression. While clinical and radiological outcomes are well-documented, the psychosocial dimensions of recovery remain underexplored.
View Article and Find Full Text PDFCarbohydr Polym
March 2025
Key Lab of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, China. Electronic address:
In an effort to mitigate or reverse the pathological progression of early-stage osteonecrosis of the femoral head (ONFH), this study employed a promising strategy that involves the sustained delivery of osteogenic factors to augment core decompression, facilitated by the use of composite hydrogels. Specifically, a hydrogel was synthesized by blending chitosan, Pluronic F-127, and tripolyphosphate, utilizing both ionic bonding and copolymer micelle cross-linking techniques. This hydrogel demonstrated exceptional biocompatibility, temperature responsiveness, pH-dependent biodegradation, and controlled release properties.
View Article and Find Full Text PDFFront Pharmacol
January 2025
Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Background: The debate continues on whether combining core decompression (CD) with regenerative therapy provides a more effective treatment for early femoral head necrosis than CD alone. This systematic review and meta-analysis endeavored to assess its efficacy.
Methods: We systematically searched PubMed, Web of Science, and Cochrane Library through July 2024 for RCTs and cohort studies evaluating the impact of core decompression (CD) with regenerative therapy versus CD alone in early-stage osteonecrosis (ARCO I, II or IIIa or Ficat I or II) of the femoral head (ONFH).
J Hip Preserv Surg
December 2024
Department of Orthopaedics, All India Institute of Medical Sciences, Rishikesh, Dehradun 249203, India.
Osteonecrosis of femoral head (ONFH) can be a debilitating disease, for which numerous salvage surgeries have been popularized to halt its progression. The aim of this study was to assess the clinical and radiological outcomes of a single-incision core decompression (CD) technique using trochanteric autograft in ONFH and to determine the prognostic factors of treatment success. Sixty-six hips (41 patients) of Association Research Circulation (ARCO) 1 and 2 ONFH undergoing CD were included in the study with a mean follow-up of 58 months.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!